WHO ICTRP trial
A randomized, double-blind, placebo parallel-controlled, multi-center clinical…
ChiCTR2400080840 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400080840 |
|---|---|
| Public title | A randomized, double-blind, placebo parallel-controlled, multi-center clinical trial to investigate the efficacy and safety of Bushen Xiaoyu Xiezhuo Formula in the treatment of diabetic kidney disease with kidney deficiency and stasis type |
| Scientific title | A randomized, double-blind, placebo parallel-controlled, multi-center clinical trial to investigate the efficacy and safety of Bushen Xiaoyu Xiezhuo Formula in the treatment of diabetic kidney disease with kidney deficiency and stasis type |
| Primary sponsor | The First Affiliated Hospital of Zhejiang Chinese Medicine University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | diabetic kidney disease |
| Interventions | treatment group:Bushen Xiaoyu Xiezhuofang granules, 2 times a day, 2 bags each time, taken with boiling water;control group:Bushen Xiaoyu Xiezhuo granules mimics, 2 times a day, 2 bags each time, taken with boiling water |
| Registration date | Feb 8, 2024 |
| Target size | treatment group:60;control group:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: